Liposome protein corona characterization as a new approach in nanomedicine
This trends article describes the analytical approaches for the in-depth characterization of the protein corona on liposome nanoparticles. In particular, examples since 2014 are summarized according to the analytical approach. Traditional protein corona characterizations from in vitro static experiments are provided along with the newly introduced experimental setups for characterization of the protein corona by in vitro dynamic and in vivo studies. Additionally, a special attention is also devoted to the need for introduction of new experimental workflows for characterization of a much wider array of biomolecules. In the most recent years, an extension of the protein corona concept to the biomolecular corona was introduced, and the analytical targets are no longer restricted to proteins, but to other important biomolecules as well, as they can potentially affect the biodistribution and interaction of nanoparticles with the biological systems. The few recent examples in this field are discussed for the characterization of metabolites and lipids in the biomolecular corona with examples, also extending the discussion from liposome to other types of nanoparticles. A final discussion is provided on the potential key role of the most recent omics approaches in the study of the nano-bio interface, with an overview on top-down proteomics, which allows a better elucidation of proteoforms, and on lipidomics and metabolomics, which allow a comprehensive untargeted characterization of lipids and metabolites, respectively.
KeywordsLiposomes Biomolecular corona Protein corona Proteomics Metabolomics Lipidomics
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 9.Tavano R, Gabrielli L, Lubian E, Fedeli C, Visentin S, Polverino De Laureto P, et al. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes. ACS Nano. 2018;12:5834–47. https://doi.org/10.1021/acsnano.8b01806.CrossRefGoogle Scholar
- 17.Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, Palchetti S, et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale. 2014;6:2782–92. https://doi.org/10.1039/c3nr05559k.CrossRefGoogle Scholar
- 20.Capriotti AL, Caracciolo G, Caruso G, Cavaliere C, Pozzi D, Samperi R, et al. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal Bioanal Chem. 2010;398:2895–903. https://doi.org/10.1007/s00216-010-4104-y.CrossRefGoogle Scholar
- 22.Benne N, van Duijn J, Lozano Vigario F, Leboux RJT, van Veelen P, Kuiper J, et al. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. J Control Release. 2018;291:135–46. https://doi.org/10.1016/j.jconrel.2018.10.028.CrossRefGoogle Scholar
- 25.Arcella A, Palchetti S, Digiacomo L, Pozzi D, Capriotti AL, Frati L, et al. Brain targeting by liposome-biomolecular corona boosts anti-cancer efficacy of temozolomide in glioblastoma cells. ACS Chem Neurosci. 2018. https://doi.org/10.1021/acschemneuro.8b00339.
- 27.Palchetti S, Pozzi D, Capriotti AL, La Barbera G, Chiozzi RZ, Digiacomo L, et al. Influence of dynamic flow environment on nanoparticle-protein corona: from protein patterns to uptake in cancer cells. Colloids Surfaces B Biointerfaces. 2017;153:263–71. https://doi.org/10.1016/j.colsurfb.2017.02.037.CrossRefGoogle Scholar
- 31.Itoh N, Kimoto A, Yamamoto E, Higashi T, Santa T, Funatsu T, et al. High performance liquid chromatography analysis of 100-nm liposomal nanoparticles using polymer-coated, silica monolithic columns with aqueous mobile phase. J Chromatogr A. 2017;1484:34–40. https://doi.org/10.1016/j.chroma.2016.12.080.CrossRefGoogle Scholar
- 49.Raesch SS, Tenzer S, Storck W, Rurainski A, Selzer D, Ruge CA, et al. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano. 2015;9:11872–85. https://doi.org/10.1021/acsnano.5b04215.CrossRefGoogle Scholar
- 57.Schaffer LV, Rensvold JW, Shortreed MR, Cesnik AJ, Jochem A, Scalf M, et al. Identification and quantification of murine mitochondrial proteoforms using an integrated top-down and intact-mass strategy. J Proteome Res. 2018;17:3526–36. https://doi.org/10.1021/acs.jproteome.8b00469.CrossRefGoogle Scholar
- 60.McCool EN, Lubeckyj RA, Shen X, Chen D, Kou Q, Liu X, et al. Deep top-down proteomics using capillary zone electrophoresis-tandem mass spectrometry: identification of 5700 proteoforms from the Escherichia coli proteome. Anal Chem. 2018;90:5529–33. https://doi.org/10.1021/acs.analchem.8b00693.CrossRefGoogle Scholar
- 64.La Barbera G, Antonelli M, Cavaliere C, Cruciani G, Goracci L, Montone CM, et al. Delving into the polar lipidome by optimized chromatographic separation, high-resolution mass spectrometry, and comprehensive identification with Lipostar: microalgae as case study. Anal Chem. 2018;90:12230–8. https://doi.org/10.1021/acs.analchem.8b03482.CrossRefGoogle Scholar